SAMDaily.us | PRESOL | A | 2-PAM Autoinjectors Project Bioshield

SAMDAILY.US - ISSUE OF JUNE 04, 2026 SAM #8956
SOLICITATION NOTICE

A -- 2-PAM Autoinjectors Project Bioshield

Notice Date: 6/2/2026 9:31:10 AM
Notice Type: Presolicitation
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
ZIP Code: 20515
Solicitation Number: 75A50126R00002
Response Due: 6/16/2026 2:00:00 PM
Archive Date: 07/01/2026
Point of Contact: Erin Greninger, Contracting Officer, Greg Smith
E-Mail Address: erin.greninger@hhs.gov, greg.smith1@hhs.gov
(erin.greninger@hhs.gov, greg.smith1@hhs.gov)
Small Business Set-Aside: NONE No Set aside used
Description: This is a presoliciation notice for the following: BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Web Link: SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/42cede8dc5024748a83d52058e6dd1d4/view)
Place of Performance: Address: Washington, DC 20024, USA; Zip Code: 20024; Country: USA
Record: SN07836794-F 20260604/260602230043 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |